$22.07
-0.20-0.88%
Last update: Sep 2, 3:34 PM
Latigo Biotherapeutics Inc (LTGO) Stock Price, Quote, News & History
LTGONASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Latigo Biotherapeutics (LTGO) stock?
You can purchase shares of Latigo Biotherapeutics (NASDAQ:LTGO) through any online brokerage.
Who are Latigo Biotherapeutics (LTGO) competitors?
Other companies in Latigo Biotherapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
What is the forecast, or price target, for Latigo Biotherapeutics (LTGO) stock?
Latigo Biotherapeutics has a consensus price target of $45.33.
What is the current price for Latigo Biotherapeutics (LTGO)?
The stock price for Latigo Biotherapeutics (NASDAQ: LTGO) is $22.065 last updated September 2, 2026 at 3:34 PM EDT.
Does Latigo Biotherapeutics (LTGO) pay a dividend?
There are no upcoming dividends for Latigo Biotherapeutics.
When is Latigo Biotherapeutics (NASDAQ:LTGO) reporting earnings?
Latigo Biotherapeutics does not have any upcoming earnings scheduled.
Is Latigo Biotherapeutics (LTGO) going to split?
There is no upcoming split for Latigo Biotherapeutics.
What sector and industry does Latigo Biotherapeutics (LTGO) operate in?
Latigo Biotherapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
